Abbott’s COVID-19 test sales dive by nearly 90%
by Lisa Schencker, Chicago Tribune
Jul 20, 2023
1 minute
Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on from the pandemic.
North suburban-based rapid, at-home COVID-19 test BinaxNOW. From April through June, Abbott sold $263 million worth of COVID-19 tests, compared with $2.3 billion during the same time last year.
You’re reading a preview, subscribe to read more.
Start your free 30 days